Ruffolo R R, Yaden E L
J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1011-9.
The existence of a receptor reserve (spare receptors) was investigated for postsynaptic vascular alpha1- and alpha2-adrenoceptors in the pithed rat by evaluating the effects of progressive inactivation of alpha1- and alpha2-adrenoceptor pools by the irreversible antagonist phenoxybenzamine on the pressor responses of cirazoline and B-HT 933. Dose-response curves for the alpha1-adrenoceptor-mediated vasoconstrictor effects of cirazoline were shifted in a rightward direction with no depression of the maximum response by lower does of phenoxybenzamine (0.1-0.2 mg/kg, i.v.). Progressively higher doses of phenoxybenzamine (greater than 1 mg/kg, i.v.) produced further rightward shifts in the dose-response curves of cirazoline, but also depressed the maximum response. In contrast, all doses of phenoxybenzamine that inhibited the alpha2-adrenoceptor-mediated pressor effects of B-HT 933 produced a reduction in the maximum response. These results are highly suggestive of the existence of a receptor reserve in the pithed rat for the postsynaptic vascular alpha1-adrenoceptor-mediated effects of cirazoline, but not for the postsynaptic vascular alpha2-adrenoceptor-mediated effects of B-HT 933. Confirmation of the existence of a receptor reserve for only the postsynaptic vascular alpha1-adrenoceptor-mediated effects of cirazoline came from further analysis of the antagonism, by phenoxybenzamine, of cirazoline and B-HT 933 dose-response curves. The maximum pressor response that could be elicited by the alpha1-adrenoceptor agonist cirazoline was a hyperbolic function on the size of the alpha1-adrenoceptor pool, the latter being progressively decreased by phenoxybenzamine treatment. Such a hyperbolic relationship is indicative of a receptor reserve. In marked contrast, the maximum pressor response that could be evoked by the alpha2-adrenoceptor agonist B-HT 933 was a linear function of the size of the intact alpha2-adrenoceptor pool, characteristic of a lack of spare receptors. Further analysis showed that the occupancy-response relationship is fivefold more favorable for the alpha1-adrenoceptor-mediated pressor effects of cirazoline than for the alpha2-adrenoceptor-mediated pressor effects of B-HT 933, indicating that any given maximum pressor response in the pithed rat may be obtained with one-fifth as many alpha1-adrenoceptors being activated by cirazoline than alpha2-adrenoceptors being stimulated by B-HT 933. (ABSTRACT TRUNCATED AT 250 WORDS)
通过评估不可逆拮抗剂酚苄明对可乐唑啉和B-HT 933升压反应的影响,研究了脊髓麻醉大鼠突触后血管α1和α2肾上腺素能受体的受体储备(备用受体)的存在情况。可乐唑啉由α1肾上腺素能受体介导的血管收缩作用的剂量反应曲线向右移动,较低剂量的酚苄明(0.1 - 0.2 mg/kg,静脉注射)未使最大反应降低。逐渐增加酚苄明的剂量(大于1 mg/kg,静脉注射)使可乐唑啉的剂量反应曲线进一步右移,但也降低了最大反应。相比之下,所有抑制B-HT 933由α2肾上腺素能受体介导的升压作用的酚苄明剂量均使最大反应降低。这些结果强烈提示脊髓麻醉大鼠中存在受体储备介导可乐唑啉的突触后血管α1肾上腺素能受体效应,但不存在于介导B-HT 933的突触后血管α2肾上腺素能受体效应中。仅针对可乐唑啉的突触后血管α1肾上腺素能受体介导效应存在受体储备的确认来自对酚苄明对可乐唑啉和B-HT 933剂量反应曲线拮抗作用的进一步分析。α1肾上腺素能受体激动剂可乐唑啉可引发的最大升压反应是α1肾上腺素能受体池大小的双曲线函数,后者经酚苄明处理后逐渐减少。这种双曲线关系表明存在受体储备。与之形成鲜明对比的是,α2肾上腺素能受体激动剂B-HT 933可引发的最大升压反应是完整α2肾上腺素能受体池大小的线性函数,这是缺乏备用受体的特征。进一步分析表明,占据-反应关系对于可乐唑啉的α1肾上腺素能受体介导的升压作用比B-HT 933的α2肾上腺素能受体介导的升压作用有利五倍,这表明在脊髓麻醉大鼠中,可乐唑啉激活α1肾上腺素能受体产生任何给定最大升压反应所需的受体数量仅为B-HT 933刺激α2肾上腺素能受体所需数量的五分之一。(摘要截短于250字)